Researchers at the University of California, Irvine, have developed a polymeric biohybrid cardiac device that harnesses the ...
A new MRI method measures cardiac oxygen use in three minutes without catheters or radiation, offering a simpler way to study ...
The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...
Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...
BACKGROUND: Survival after Fontan palliation for single ventricle heart disease has improved substantially, yet the long-term ...
Medtronic plc (NYSE:MDT) is one of the 7 Most Undervalued Blue Chip Stocks to Invest In. On March 23, 2026, Medtronic plc ...
Medical societies are urging the adoption of ALARA+, the new cath lab standard of "as low and as light as reasonably ...
Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging ...
Heart disease claims 28.6 lakh lives annually in India, yet access to timely treatment remains severely inadequate, ...
A 173-patient randomized trial in HFrEF (LVEF ≤35%) with LBBB (QRS ≥130 ms) showed CSP was inferior to BiVP for a hierarchical 12‑month composite endpoint. Worse outcomes with CSP were reflected by an ...
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc ...
Irish medtech giant Medtronic has secured another US approval for its OmniaSecure defibrillation lead, expanding its use to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results